| 1 |
2023 |
Shanshan Hu, Yilai Wu, Jiajie Luan, Shuowen Wang, Guorong Fan. Cost–utility analysis of trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer in Chinese setting, Journal of Cancer Research and Clinical Oncology. 2023; 149: 17933.
https://doi.org/10.1007/s00432-023-05496-2 |
| 2 |
2024 |
Chiara Tarantelli, David Wald, Nicolas Munz, Filippo Spriano, Alessio Bruscaggin, Eleonora Cannas, Luciano Cascione, Eugenio Gaudio, Alberto J. Arribas, Shivaprasad Manjappa, Gaetanina Golino, Lorenzo Scalise, Maria Teresa Cacciapuoti, Emanuele Zucca, Anastasios Stathis, Giorgio Inghirami, Patrick H. Van Berkel, Davide Rossi, Paolo F. Caimi, Francesca Zammarchi, Francesco Bertoni. Targeting CD19-positive lymphomas with the antibodydrug conjugate loncastuximab tesirine: preclinical evidence of activity as a single agent and in combination therapy, Haematologica. 2024; 109: 3314.
https://doi.org/10.3324/haematol.2023.284197 |
| 3 |
2025 |
Alireza Shoari, From Bench to Bedside: Transforming Cancer Therapy with Protease Inhibitors, Targets. 2025; 3: 8.
https://doi.org/10.3390/targets3010008 |
| 4 |
2022 |
Afua Adjeiwaa Mensah, Patrizia Mondello. Harnessing the Molecular Fingerprints of B Cell Lymphoma for Precision Therapy, Journal of Clinical Medicine. 2022; 11: 5834.
https://doi.org/10.3390/jcm11195834 |
| 5 |
2023 |
Chiara Tarantelli, David Wald, Nicolas Munz, Filippo Spriano, Alessio Bruscaggin, Eleonora Cannas, Luciano Cascione, Eugenio Gaudio, Alberto J. Arribas, Shivaprasad Manjappa, Gaetanina Golino, Lorenzo Scalise, Emanuele Zucca, Anastasios Stathis, Patrick H. van Berkel, Davide Rossi, Paolo F. Caimi, Francesca Zammarchi, Francesco Bertoni. 2023;
https://doi.org/10.1101/2023.08.17.553668 |
| 6 |
2025 |
Gulrayz Ahmed, Mehdi Hamadani, Taha Al-Juhaishi. The potential of antibody-drug conjugates for effective therapy in diffuse large B-cell lymphoma, Expert Opinion on Biological Therapy. 2025; 25: 161.
https://doi.org/10.1080/14712598.2025.2453524 |
| 7 |
2024 |
Ana Luisa Rivera-Lazarín, Kenny Misael Calvillo-Rodríguez, Mizael Izaguirre-Rodríguez, José Manuel Vázquez-Guillén, Ana Carolina Martínez-Torres, Cristina Rodríguez-Padilla. Synergistic Enhancement of Chemotherapy-Induced Cell Death and Antitumor Efficacy against Tumoral T-Cell Lymphoblasts by IMMUNEPOTENT CRP, International Journal of Molecular Sciences. 2024; 25: 7938.
https://doi.org/10.3390/ijms25147938 |
| 8 |
2023 |
Filippo Spriano, Luca Aresu, Luciano Cascione, Giorgia Risi, Alberto J. Arribas, Sara Napoli, Andrea Rinaldi, Nicole Forster-Gross, Felix Bachmann, Marc Engelhardt, Heidi Lane, Francesco Bertoni. 2023;
https://doi.org/10.1101/2022.12.31.521730 |
| 9 |
2024 |
Filippo Spriano, Chiara Tarantelli, Luciano Cascione, Eugenio Gaudio, Gaetanina Golino, Lorenzo Scalise, Maria Teresa Cacciapuoti, Emanuele Zucca, Anastasios Stathis, Patrick H. Van Berkel, Giorgio Inghirami, Francesca Zammarchi, Francesco Bertoni. Targeting CD25+ lymphoma cells with the antibody–drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents, British Journal of Haematology. 2024; 205: 1873.
https://doi.org/10.1111/bjh.19658 |
| 10 |
2024 |
Adrian-Bogdan Tigu, Raluca Munteanu, Cristian Moldovan, Drula Rares, David Kegyes, Radu Tomai, Vlad Moisoiu, Gabriel Ghiaur, Ciprian Tomuleasa, Hermann Einsele, Diana Gulei, Carlo M. Croce. Therapeutic advances in the targeting of ROR1 in hematological cancers, Cell Death Discovery. 2024; 10: 471.
https://doi.org/10.1038/s41420-024-02239-1 |
| 11 |
2024 |
Chufeng Zhang, Wei Yan, Yan Liu, Minghai Tang, Yaxin Teng, Fang Wang, Xiuying Hu, Min Zhao, Jianhong Yang, Yong Li. Structure-based design and synthesis of BML284 derivatives: A novel class of colchicine-site noncovalent tubulin degradation agents, European Journal of Medicinal Chemistry. 2024; 268: 116265116265.
https://doi.org/10.1016/j.ejmech.2024.116265 |
| 12 |
2023 |
Filippo Spriano, Chiara Tarantelli, Luciano Cascione, Eugenio Gaudio, Gaetanina Golino, Lorenzo Scalise, Emanuele Zucca, Anastasios Stathis, Patrick H. Van Berkel, Francesca Zammarchi, Francesco Bertoni. 2023;
https://doi.org/10.1101/2023.07.02.547392 |
| 13 |
2023 |
Katrin Schoenfeld, Julia Harwardt, Jan Habermann, Adrian Elter, Harald Kolmar. Conditional activation of an anti-IgM antibody-drug conjugate for precise B cell lymphoma targeting, Frontiers in Immunology. 2023; 14: 1258700.
https://doi.org/10.3389/fimmu.2023.1258700 |
| 14 |
2024 |
Stefano Zoroddu, Luca Sanna, Valentina Bordoni, Lyu Weidong, Sergio Domenico Gadau, Antonio Carta, David J. Kelvin, Luigi Bagella. Identification of 3-Aryl-1-benzotriazole-1-yl-acrylonitrile as a Microtubule-Targeting Agent (MTA) in Solid Tumors, International Journal of Molecular Sciences. 2024; 25: 5704.
https://doi.org/10.3390/ijms25115704 |
| 15 |
2024 |
Magdalena Witkowska, Agata Majchrzak, Paweł Robak, Anna Wolska-Washer, Tadeusz Robak. The role of antibody therapies in treating relapsed chronic lymphocytic leukemia: a review, Expert Opinion on Biological Therapy. 2024; 24: 1233.
https://doi.org/10.1080/14712598.2024.2413365 |
| 16 |
2024 |
Dowdy Jackson, The Highs, Lows, and Resurgence of Antibody-drug Conjugates, ADC Review / Journal of Antibody-drug Conjugates. 2024;
https://doi.org/10.14229/jadc.2024.07.02.001 |
| 17 |
2024 |
Ali Al Sbihi, Maryam Alasfour, Georgios Pongas. Innovations in Antibody-Drug Conjugate (ADC) in the Treatment of Lymphoma, Cancers. 2024; 16: 827.
https://doi.org/10.3390/cancers16040827 |
